Media Center

enGenes participates in the study of large scale production strategies for microbial carbohydrate-binding toxins

Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have collaborated with researchers...

Vienna, Austria: – Scientists from recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) have co-authored a new study that...

enGenes Biotech has developed a leading-edge platform for the customized production of recombinant proteins and plasmid DNA that can...

Vienna, Austria: – Recombinant protein specialist manufacturer enGenes Biotech GmbH (enGenes) will present its innovative decoupled...

enGenes -express achieves high yield SARS CoV-2 nucleocapsid protein expression News-ReleasesEnGenes Biotech GmbH August 26th 2021...

New study shows ecological benefits for enGenes Biotech -express technology News-ReleasesEnGenes Biotech GmbH March 4th 2021 Vienna,...

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) has co-authored new studies that highlight the...

Vienna, Austria: -Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) has produced original research showing how a novel...

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) has joined forces with Technical University Vienna...

A major advantage of enGenes Biotech’s proprietary -eXpress™ proprietary technology platform for outstanding recombinant protein...